Price
Prices are end-of-day closes. This is a research view, the focus is on the fundamentals, quality and valuation below, not intraday price.
Smart Score
Top tierIDEXX was incorporated in Delaware in 1983. We develop, manufacture, and distribute products and provide services primarily for the companion animal veterinary; livestock, poultry and dairy; and water testing industries. We also manufacture and sell human medical point-of-care diagnostic products. Our primary products and services are: Our Purpose is to be a great company that creates exceptional long-term value for our customers, employees, and stockholders by enhancing the health and well-being of pets, people, and livestock.
In the company’s own words · 10-K filed Feb 20, 2026 · SEC EDGAR
Business segments
Q1 2026 · $1.15BThe company’s own SEC segment disclosure.
- Vet Lab Consumables$412.6M36%
- Reference Laboratory Diagnostic And Consulting Services$386.2M34%
- Veterinary Software Services And Diagnostic Imaging Systems$91.3M8%
- Rapid Assay Products$84.9M7%
- Recurring$73.5M6%
- CAG Diagnostic Capital Instruments$42.4M4%
- Other (2)$54.4M5%
Idexx Laboratories (IDXX) reported revenue of $1.22B in Q2 2026 (quarter ended June 30, 2026), up 9.7% from the same quarter a year earlier. That came with a gross margin of 64% and net income of $338M (28% of revenue). For the full year FY2025, revenue was $4.30B (+10% year on year) and net income $1.06B. Its largest product in 2026-Q1 was Vet Lab Consumables at $413M, 36% of the disclosed total, just ahead of Reference Laboratory Diagnostic And Consulting Services at 34%.
Raw charts
11 series · TTMAs reported to the SEC, without any scoring.
Diagnostics & Research
Ranks #10 of 29 by Smart Score